Recent Finacing
Recent Raise
Apollon develops a needle-free glucose monitor using Raman spectroscopy, holds device patents, runs clinical trials with MIT and Joslin, with R&D teams in Boston and Seoul pursuing FDA approval.
Focus Areas
Recent Investors
Funding round
Investors
See the team members at Apollon.
